The University of Chicago Header Logo

Connection

Walter M. Stadler to Drug Design

This is a "connection" page, showing publications Walter M. Stadler has written about Drug Design.
Connection Strength

0.615
  1. Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development. Clin Cancer Res. 2007 Mar 15; 13(6):1630-3.
    View in: PubMed
    Score: 0.288
  2. Developing drugs that do not cause tumor regression. Clin Adv Hematol Oncol. 2003 Nov; 1(11):654-5.
    View in: PubMed
    Score: 0.228
  3. Angiogenesis inhibitors in genitourinary cancers. Crit Rev Oncol Hematol. 2003 Jun 27; 46 Suppl:S41-7.
    View in: PubMed
    Score: 0.056
  4. Development of target-based antineoplastic agents. Invest New Drugs. 2000 Feb; 18(1):7-16.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.